These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 17992452

  • 1. Anaphylaxis after Hymenoptera sting without detectable specific IgE.
    Zidarn M, Kosnik M, Drinovec I.
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Mar; 16(1):31-3. PubMed ID: 17992452
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH, Farhoudi A, Pourpak Z, Gharagozlou M, Movahedi M, Nabavi M, Mozafari H, Mohammadzadeh I, Chavoshzadeh Z, Shirkhoda Z.
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [Abstract] [Full Text] [Related]

  • 4. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
    Sturm GJ, Heinemann A, Schuster C, Wiednig M, Groselj-Strele A, Sturm EM, Aberer W.
    Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R, Glück J, Jawor B, Rogala B.
    Immunopharmacol Immunotoxicol; 2015 Aug; 37(4):375-9. PubMed ID: 26181651
    [Abstract] [Full Text] [Related]

  • 7. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 Aug; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New directions in diagnostic evaluation of insect allergy.
    Golden DB.
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):334-9. PubMed ID: 24915545
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A, Hofbauer G, Ballmer-Weber BK, Schmid-Grendelmeier P.
    J Investig Allergol Clin Immunol; 2006 Aug; 16(2):79-85. PubMed ID: 16689180
    [Abstract] [Full Text] [Related]

  • 16. Natural history of Hymenoptera venom sensitivity in adults.
    Golden DB, Marsh DG, Freidhoff LR, Kwiterovich KA, Addison B, Kagey-Sobotka A, Lichtenstein LM.
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):760-6. PubMed ID: 9438483
    [Abstract] [Full Text] [Related]

  • 17. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D, Bircher AJ, Scherer K.
    J Investig Allergol Clin Immunol; 2011 Dec; 21(1):22-7. PubMed ID: 21370719
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Value of specific IgE and IgG4 measurements in the follow-up of a hymenoptera venom immunotherapy treatment: apropos of 82 cases].
    Sonneville A, Loustanau O, Tahar HA, Menelet I.
    Allerg Immunol (Paris); 2000 Jan; 32(1):20-5. PubMed ID: 10723532
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.